Science | Nature | Cell | View More
Natural Products
Crotaline
ChemFaces products have been cited in many studies from excellent and top scientific journals
Product Name Crotaline
Price: $40 / 20mg
CAS No.: 315-22-0
Catalog No.: CFN98135
Molecular Formula: C16H23NO6
Molecular Weight: 325.36 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Source: The herbs of Crotalaria pallida Ait.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download: COA    MSDS    SDF    Manual
Similar structural: Comparison (Web)  (SDF)
Guestbook:
Contact Us
Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC
How to Order
Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com
Delivery time
Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal
Citing Use of our Products
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
Size /Price /Stock 10 mM * 1 mL in DMSO / $10.8 / In-stock
Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
Our products had been exported to the following research institutions and universities, And still growing.
  • University of Fribourg (Switzerland)
  • University of Sao Paulo (Brazil)
  • Helmholtz Zentrum München (Germany)
  • Universidade da Beira Interior (Germany)
  • University of Illinois (USA)
  • Sapienza University of Rome (Italy)
  • Utah State University (USA)
  • University Medical Center Mainz (Germany)
  • Georgia Institute of Technology (USA)
  • Molecular Biology Institute of ... (Spain)
  • Ateneo de Manila University (Philippines)
  • More...
Package
Featured Products
Sweroside

Catalog No: CFN99455
CAS No: 14215-86-2
Price: $40/20mg
Phillyrin

Catalog No: CFN99998
CAS No: 487-41-2
Price: $30/20mg
Arctiin

Catalog No: CFN99991
CAS No: 20362-31-6
Price: $30/20mg
Damulin B

Catalog No: CFN91837
CAS No: 1202868-75-4
Price: $288/5mg
20-O-Glucoginsenoside Rf

Catalog No: CFN95036
CAS No: 68406-27-9
Price: $318/5mg
Coniferin

Catalog No: CFN98886
CAS No: 531-29-3
Price: $288/20mg
Isoschaftoside

Catalog No: CFN92029
CAS No: 52012-29-0
Price: $118/20mg
Procyanidin B4

Catalog No: CFN91171
CAS No: 29106-51-2
Price: $288/10mg
Ascorbic acid

Catalog No: CFN90048
CAS No: 50-81-7
Price: $30/20mg
Diosmin

Catalog No: CFN98145
CAS No: 520-27-4
Price: $30/20mg
Related Screening Libraries
Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries
Biological Activity
Description: Crotaline venoms produce various toxic effects, although these are most commonly treated with specific antivenoms. Monocrotaline is an 11-membered macrocyclic pyrrolizidine alkaloid (PA) that causes a pulmonary vascular syndrome in rats characterized by proliferative pulmonary vasculitis, pulmonary hypertension, and cor pulmonale.
Targets: IL Receptor
In vitro:
Anticancer Agents Med Chem. 2014;14(9):1237-48.
Antineoplastic activity of monocrotaline against hepatocellular carcinoma.[Pubmed: 25028149]
Plants are fantastic sources for present day life saving drugs. MonoCrotaline a natural ligand exhibits dose-dependent cytotoxicity with potent antineoplastic activity. This study was intended to disclose the therapeutic potential of monoCrotaline against hepatocellular carcinoma.
METHODS AND RESULTS:
The in silico predictions have highlighted the antineoplastic potential, druglikeness and biodegradability of monoCrotaline. The in silico docking study has provided an insight and evidence for the antineoplastic activity of monoCrotaline against p53, HGF and TREM1 proteins which play a threatening role in causing hepatocellular carcinoma. The mode of action of monoCrotaline was determined experimentally by in vitro techniques such as XTT assay, NRU assay and whole cell brine shrimp assay have further supported our in silico studies.
CONCLUSIONS:
The in vitro cytotoxicity of monoCrotaline was proved at IC50 24.966 μg/mL and genotoxicity at 2 X IC50 against HepG2 cells. Further, the credible druglike properties with non-mutagenicity, non-toxic on mammalian fibroblast and the potential antineoplastic activity through in vitro experimental validations established monoCrotaline as a novel scaffold for liver cancer with superior efficacy and lesser side effects.
In vivo:
Eur J Pharm Sci. 2014 Oct 1;62:161-70.
Naringenin adds to the protective effect of L-arginine in monocrotaline-induced pulmonary hypertension in rats: favorable modulation of oxidative stress, inflammation and nitric oxide.[Pubmed: 24878387]
The present study was directed to investigate the possible modulatory effect of naringenin when co-administered with L-arginine in monoCrotaline-induced pulmonary hypertension in rats.
METHODS AND RESULTS:
Pulmonary hypertension was induced by a single subcutaneous injection of monoCrotaline (60 mg/kg). L-arginine (500 mg/kg) and naringenin (50 mg/kg) were orally administered daily, alone and in combination, for 3 weeks. Mean arterial blood pressure, electrocardiography and echocardiography were then recorded and rats were sacrificed and serum was separated for determination of total nitrate/nitrite level. Right ventricles and lungs were isolated for estimation of oxidative stress markers, tumor necrosis factor-alpha, total nitrate/nitrite and transforming growth factor-beta. Myeloperoxidase and caspase-3 activities in addition to endothelial and inducible nitric oxide synthase protein expression were also determined. Moreover, histological analysis of pulmonary arteries and cardiomyocyte cross-sectional area was performed. Combined therapy provided a significant improvement in L-arginine protective effect toward preserving hemodynamic changes and alleviating oxidative stress, inflammatory and apoptotic markers induced by monoCrotaline treatment. Furthermore, combined therapy prevented monoCrotaline-induced changes in endothelial and inducible nitric oxide synthase protein expression as well as histological analysis compared with either treatment alone.
CONCLUSIONS:
In conclusion, naringenin significantly adds to the protective effect of L-arginine in pulmonary hypertension induced by monoCrotaline in rats.
Ann Emerg Med. 2001 Feb;37(2):175-80.
Role of surgical intervention in the management of crotaline snake envenomation.[Pubmed: 11174236 ]
Crotaline venoms produce various toxic effects. Although these are most commonly treated with specific antivenoms, surgical management of snakebite has also been practiced for many years.
METHODS AND RESULTS:
Surgical approaches to pit viper envenomation include incision or excision of the bite site, fasciotomy, and digit dermotomy. The evidence regarding each of these procedures is sparse; however, incision or excision of the bite site are difficult to advocate.
CONCLUSIONS:
Fasciotomy and digit dermotomy may be appropriate in carefully selected patients.
Crotaline Description
Source: The herbs of Crotalaria pallida Ait.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
N-Demethylfordianoside

Catalog No: CFN95589
CAS No: N/A
Price: $318/10mg
Oxytroflavoside F

Catalog No: CFN95489
CAS No: 1391144-85-6
Price: $318/5mg
New compound 18

Catalog No: CFN95527
CAS No: N/A
Price: $413/5mg
3-Hydroxy-4',5-dimethoxystilbene

Catalog No: CFN95199
CAS No: 58436-29-6
Price: $318/10mg
Parvisoflavanone

Catalog No: CFN95077
CAS No: 49776-79-6
Price: $413/5mg
Malabaricone A

Catalog No: CFN95477
CAS No: 63335-23-9
Price: $318/10mg
Isoedultin

Catalog No: CFN95273
CAS No: 43043-08-9
Price: $318/5mg
1,3,4,6-Tetragalloylglucose

Catalog No: CFN95425
CAS No: 26922-99-6
Price: $318/10mg
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

Cell. 2018 Jan 11;172(1-2):249-261.e12.
doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)

PMID: 29328914

Cell Metab. 2020 Mar 3;31(3):534-548.e5.
doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)

PMID: 32004475

Mol Cell. 2017 Nov 16;68(4):673-685.e6.
doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)

PMID: 29149595

ACS Nano. 2018 Apr 24;12(4): 3385-3396.
doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)

PMID: 29553709

Nature Plants. 2016 Dec 22;3: 16206.
doi: 10.1038/nplants.2016.205.
IF=13.297(2019)

PMID: 28005066

Sci Adv. 2018 Oct 24;4(10): eaat6994.
doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)

PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.0735 mL 15.3676 mL 30.7352 mL 61.4704 mL 76.838 mL
5 mM 0.6147 mL 3.0735 mL 6.147 mL 12.2941 mL 15.3676 mL
10 mM 0.3074 mL 1.5368 mL 3.0735 mL 6.147 mL 7.6838 mL
50 mM 0.0615 mL 0.3074 mL 0.6147 mL 1.2294 mL 1.5368 mL
100 mM 0.0307 mL 0.1537 mL 0.3074 mL 0.6147 mL 0.7684 mL
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
Protocol
Kinase Assay:
Int Heart J. 2015 May 13;56(3):354-9.
Delivery of imatinib-incorporated nanoparticles into lungs suppresses the development of monocrotaline-induced pulmonary arterial hypertension.[Pubmed: 25902888]
Platelet-derived growth factor (PDGF) is implicated in the pathogenesis of pulmonary arterial hypertension (PAH). Imatinib, a PDGF-receptor tyrosine kinase inhibitor, improved hemodynamics, but serious side effects and drug discontinuation are common when treating PAH. A drug delivery system using nanoparticles (NPs) enables the reduction of side effects while maintaining the effects of the drug.
METHODS AND RESULTS:
We examined the efficacy of imatinib-incorporated NPs (Ima-NPs) in a rat model and in human PAH-pulmonary arterial smooth muscle cells (PASMCs). Rats received a single intratracheal administration of PBS, FITC-NPs, or Ima-NPs immediately after monoCrotaline injection. Three weeks after monoCrotaline injection, intratracheal administration of Ima-NPs suppressed the development of pulmonary hypertension, small pulmonary artery remodeling, and right ventricular hypertrophy in the rat model of monoCrotaline-induced PAH. We also examined the effects of imatinib and Ima-NPs on PDGF-induced proliferation of human PAH-PASMCs by (3)H-thymidine incorporation. Imatinib and Ima-NPs significantly inhibited proliferation after 24 hours of treatment. Ima-NPs significantly inhibited proliferation compared with imatinib at 24 hours after removal of these drugs.
CONCLUSIONS:
Delivery of Ima-NPs into lungs suppressed the development of MCT-induced PAH by sustained antiproliferative effects on PAS-MCs.
Animal Research:
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1539-47.
Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.[Pubmed: 24790141]
Interleukin-8 (IL-8) receptors IL8RA and IL8RB (IL8RA/B) on neutrophil membranes bind to IL-8 with high affinity and play a critical role in neutrophil recruitment to sites of injury and inflammation. This study tested the hypothesis that administration of rat pulmonary arterial endothelial cells (ECs) overexpressing IL8RA/B can accelerate the adhesion of ECs to the injured lung and inhibit monoCrotaline-induced pulmonary inflammation, arterial thickening and hypertension, and right ventricular hypertrophy.
METHODS AND RESULTS:
The treatment groups included 10-week-old ovariectomized Sprague-Dawley rats that received subcutaneous injection of PBS (vehicle), a single injection of monoCrotaline (monoCrotaline alone, 60 mg/kg, SC), monoCrotaline followed by intravenous transfusion of ECs transduced with the empty adenoviral vector (null-EC), and monoCrotaline followed by intravenous transfusion of ECs overexpressing IL8RA/B (1.5 × 10(6) cells/rat). Two days or 4 weeks after monoCrotaline treatment, endothelial nitric oxide synthase, inducible nitric oxide synthase, cytokine-induced neutrophil chemoattractant-2β (IL-8 equivalent in rat), and monocyte chemoattractant protein-1 expression, neutrophil and macrophage infiltration into pulmonary arterioles, and arteriolar and alveolar morphology were measured by histological and immunohistochemical techniques. Proinflammatory cytokine/chemokine protein levels were measured by Multiplex rat-specific magnetic bead-based sandwich immunoassay in total lung homogenates. Transfusion of ECs overexpressing IL8RA/B significantly reduced monoCrotaline-induced neutrophil infiltration and proinflammatory mediator (IL-8, monocyte chemoattractant protein-1, inducible nitric oxide synthase, cytokine-induced neutrophil chemoattractant, and macrophage inflammatory protein-2) expression in lungs and pulmonary arterioles and alveoli, pulmonary arterial pressure, and pulmonary arterial and right ventricular hypertrophy and remodeling.
CONCLUSIONS:
These provocative findings suggest that targeted delivery of ECs overexpressing IL8RA/B is effective in repairing the injured pulmonary vasculature.
Sweroside

Catalog No: CFN99455
CAS No: 14215-86-2
Price: $40/20mg
Phillyrin

Catalog No: CFN99998
CAS No: 487-41-2
Price: $30/20mg
Arctiin

Catalog No: CFN99991
CAS No: 20362-31-6
Price: $30/20mg
Damulin B

Catalog No: CFN91837
CAS No: 1202868-75-4
Price: $288/5mg
20-O-Glucoginsenoside Rf

Catalog No: CFN95036
CAS No: 68406-27-9
Price: $318/5mg
Coniferin

Catalog No: CFN98886
CAS No: 531-29-3
Price: $288/20mg
Isoschaftoside

Catalog No: CFN92029
CAS No: 52012-29-0
Price: $118/20mg
Procyanidin B4

Catalog No: CFN91171
CAS No: 29106-51-2
Price: $288/10mg
Ascorbic acid

Catalog No: CFN90048
CAS No: 50-81-7
Price: $30/20mg
Diosmin

Catalog No: CFN98145
CAS No: 520-27-4
Price: $30/20mg
Tags: buy Crotaline | Crotaline supplier | purchase Crotaline | Crotaline cost | Crotaline manufacturer | order Crotaline | Crotaline distributor